The aspirin lie that could leave you with one foot in the grave
The folks behind aspirin must be getting pretty desperate right now.
Last year, the feds cut right into the heart of their profit machine, refusing Bayer's push to market aspirin for the primary prevention of heart disease.
Yes, the FDA -- an agency that rarely meets a drug it's willing to foist upon the masses (and I'll have more on that in an email later today) -- actually rejected daily aspirin.
So now, the aspirin-backers are taking a new approach, putting out word that the drug will magically cut your risk of a potentially deadly colorectal cancer.
Is there a catch? You bet there's a catch: It ONLY works if you take an aspirin or two every day and ONLY if you take it for years and years on end.
But don't be fooled by the seemingly impressive numbers, which on the surface show that daily aspirin could cut the five-year risk of the disease by 27 percent. Because the truth is the five-year risk of colon cancer among healthy people is already super low -- so low that most folks only need a colonoscopy once a decade.
In fact, the supposed benefit of aspirin is so small that a placebo-controlled study published last year found you'd have to give the drug to 709 women every day for 15 years to prevent just ONE case of colon cancer.
In exchange for preventing that single cancer, between four and six women would be hospitalized for severe gastrointestinal bleeding, while up to 18 would suffer from slightly less serious bleeding problems such as ulcers and bleeding in the digestive tract.
With numbers like that, encouraging daily aspirin to prevent colon cancer isn't just wrong.
It's borderline malpractice.
That said, colorectal cancers do kill entirely too many Americans every year, striking men and women alike in equal numbers. But we can change that, starting right now -- we can shrink the number of deaths due to this disease -- and we can do it without giving millions of people a dangerous drug.
All it takes is a colonoscopy.
It's one of the most effective cancer screenings ever developed because it not only spots potentially cancerous growths, but also removes them on the spot. As a result, a recent study found that getting scoped will cut your lifetime risk of developing the disease by more than 60 percent.
But only if the doc does the job right.
Learn more in this free report from my House Calls archives.